EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Study of High-Velocity Nasal Insufflation vs Noninvasive Positive Pressure Ventilation for Emergency Type 2 Respiratory Failure: Protocol for a Noninferiority Randomized Controlled Trial

Mui Teng Chua iD, Darius Shaw Teng Pan iD, Alexander Jet Yue Ng iD, Crystal Harn Wei Soh iD, Win Sen Kuan iD

JMIR Research Protocols · 2026-08-14 · 15 · e93391-e93391

DOI: 10.2196/93391 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-08-14. Written by Mui Teng Chua and 4 co-authors. Institution: Emergency Medicine Department, National University Hospital, Singapore, Singapore. Major MEDLINE topics: Insufflation, Respiratory Insufficiency, Noninvasive Ventilation, Positive-Pressure Respiration. 30 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Type 2 respiratory failure (T2RF) is a common and high-risk presentation in the emergency department (ED). Noninvasive positive pressure ventilation (NIPPV) is a standard first-line therapy for T2RF, particularly in acute exacerbations of chronic obstructive pulmonary disease and cardiogenic pulmonary edema. However, NIPPV has limitations, including discomfort, claustrophobia, air leaks, skin injury, and aspiration that may compromise tolerance and lead to treatment failure or escalation to endotracheal intubation. High-velocity nasal insufflation (HVNI), particularly via a single-prong asymmetric cannula configuration, has been proposed to enhance dead-space washout and improve patient comfort. Despite growing interest, robust evidence of evaluation of HVNI in heterogeneous, all-cause T2RF populations in the ED remains limited.

Objective

This study aims to determine whether HVNI delivered via a single-prong nasal cannula is noninferior to standard NIPPV in improving ventilation among adult ED patients with T2RF from any cause.

Methods

This is a single-center, open-label, noninferiority randomized controlled trial conducted in the ED of a tertiary academic center. Adults aged 21 years and above with T2RF, defined as partial pressure of carbon dioxide (PaCO 2 ) above 45 mm Hg and pH below 7.35 requiring ventilatory support, will be randomized 1:1 to HVNI via a single-prong cannula or standard NIPPV. Allocation will be concealed via an independent web-based platform using variable block sizes. The primary outcome is percentage change in PaCO 2 from baseline to 60 minutes after initiation of therapy. A total of 84 patients provide 80% power and one-sided α of 2.5% assuming an SD of 6.65% and noninferiority margin of 4.3%. Analyses will use intention-to-treat and per-protocol approaches, and sensitivity analyses to address missing arterial blood gas results will be conducted. Predefined failure criteria (persistent or worsening acidosis, rising PaCO 2 , refractory hypoxemia, severe intolerance, and clinical deterioration) will trigger crossover or escalation per protocol.

Results

Ethics approval was granted by the local institutional ethics board on February 24, 2025 (reference 2024-4329). Recruitment commenced in January 2026 and is expected to be completed by June 2027. As of July 2026, a total of 19 participants have been enrolled out of a target sample of 84. Data analysis will commence following completion of enrollment, with results expected to be published by 2028.

Conclusions

Should HVNI via a single-prong cannula be shown to be noninferior to NIPPV, it may offer a practical alternative to treatment of T2RF in the ED when mask-based interfaces are poorly tolerated or contraindicated, potentially reducing the need for more invasive interventions such as endotracheal intubation and mechanical ventilation.

Subjects

MeSH terms (MEDLINE)

InsufflationRespiratory InsufficiencyNoninvasive VentilationPositive-Pressure RespirationHumansEquivalence Trials as TopicRandomized Controlled Trials as TopicEmergency Service, HospitalCannulaMaleFemale

Author keywords

hospital emergency servicenasal oxygenationnoninvasive ventilationrandomized controlled trialrespiratory acidosis

Authors and institutions

  • Emergency Medicine Department, National University Hospital, Singapore, Singapore.
  • Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Urgent Care Centre, Alexandra Hospital, Singapore, Singapore.
  • Nuffield Department of Primary Care Health Sciences, University of Oxford, 32 Woodstock Road, Oxford, England, OX2 6GG, United Kingdom, 44 7349681776.
  • Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

ORCID profiles: Mui Teng Chua, Darius Shaw Teng Pan, Alexander Jet Yue Ng, Crystal Harn Wei Soh, Win Sen Kuan

Cite

APA

Chua, M. T., Pan, D. S. T., Ng, A. J. Y., Soh, C. H. W., & Kuan, W. S. (2026). Study of High-Velocity Nasal Insufflation vs Noninvasive Positive Pressure Ventilation for Emergency Type 2 Respiratory Failure: Protocol for a Noninferiority Randomized Controlled Trial. JMIR Research Protocols, 15, e93391-e93391. https://doi.org/10.2196/93391

Vancouver

Chua MT, Pan DST, Ng AJY, Soh CHW, Kuan WS. Study of High-Velocity Nasal Insufflation vs Noninvasive Positive Pressure Ventilation for Emergency Type 2 Respiratory Failure: Protocol for a Noninferiority Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e93391-e93391. doi:10.2196/93391

BibTeX
@article{Chua2026,
  author = {Chua, Mui Teng and Pan, Darius Shaw Teng and Ng, Alexander Jet Yue and Soh, Crystal Harn Wei and Kuan, Win Sen},
  title = {Study of High-Velocity Nasal Insufflation vs Noninvasive Positive Pressure Ventilation for Emergency Type 2 Respiratory Failure: Protocol for a Noninferiority Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e93391--e93391},
  doi = {10.2196/93391}
}
Start for free →